128 results on '"Somers, Klaartje"'
Search Results
2. Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors
3. Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin
4. The polyamine transporter ATP13A3 mediates DFMO-induced polyamine uptake in neuroblastoma
5. OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis
6. Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia
7. A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction
8. Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia
9. Data from Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression
10. Supplementary Figure Legends from Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
11. Supplementary Video S1 from Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
12. Supplementary Figures from Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
13. Supplementary Materials from Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression
14. Supplementary Tables 1-5 from Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
15. Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias
16. The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression
17. Novel autoantibody markers for early and seronegative rheumatoid arthritis
18. Construction of helper plasmid-mediated dual-display phage for autoantibody screening in serum
19. Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia
20. Multiplexing approaches for autoantibody profiling in multiple sclerosis
21. Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis
22. Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
23. Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting
24. The Use of Phages and Aptamers as Alternatives to Antibodies in Medical and Food Diagnostics
25. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome
26. Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression
27. Abstract IA13: Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies
28. Optimization of High-throughput Autoantibody Profiling for the Discovery of Novel Antigenic Targets in Rheumatoid Arthritis
29. Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia
30. Potent antileukemic activity of curaxin CBL0137 against MLL‐rearranged leukemia
31. ABCC4/MRP4 contributes to the aggressiveness of Myc‐associated epithelial ovarian cancer.
32. Potent antileukemic activity of curaxin CBL0137 against MLL‐rearranged leukemia.
33. Novel therapies for high-risk leukaemia in children
34. Investigating the biological roles of ABCE1 in neuroblastoma
35. Abstract 1956: ABCE1 regulates the translational profile of neuroblastoma to drive tumor progression
36. Abstract 1942: The nicotinamide phosphoribosyltransferase (NAMPT) inhibitor, OT-82, exhibitsin vitroandin vivoefficacy against patient-derived xenograft models of high-risk acute lymphoblastic leukemia
37. Abstract 1175: Inhibition of NAMPT as a novel therapeutic strategy for infant leukemia
38. CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements
39. Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis
40. Abstract B23: Selective and rapid killing of mixed lineage leukemia and CALM-AF10 leukemia by SM7, a novel small molecule identified by chemical library screening
41. Discovery of Novel Antigenic Targets and Autoantibody Markers in Rheumatoid Arthritis
42. Antibodies Against Sperm Associated Antigen 16 as a Novel Disease Marker for Multiple Sclerosis
43. Structural basis of IL-23 antagonism by an Alphabody protein scaffold
44. Taking a closer look at Spag16 in multiple sclerosis
45. Sperm-Associated Antigen 16 Is a Novel Target of the Humoral Autoimmune Response in Multiple Sclerosis
46. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.
47. Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis
48. Citrulline‐modified phage display: A novel high‐throughput discovery approach for the identification of citrulline‐containing ligands
49. Frameshifting in the P6 cDNA Phage Display System
50. Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.